AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹47 Cr | ₹-201 Cr | ₹124 Cr | ₹28 Cr | ₹-24 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AJANTA PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹47 Cr |
| Mar2024 | ₹-201 Cr |
| Mar2023 | ₹124 Cr |
| Mar2022 | ₹28 Cr |
| Mar2021 | ₹-24 Cr |
How is Net Cash Inflow / Outflow of AJANTA PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹47 Cr | Positive | |
| Mar2024 | ₹-201 Cr | Negative | |
| Mar2023 | ₹124 Cr | 345.56 | |
| Mar2022 | ₹28 Cr | Positive | |
| Mar2021 | ₹-24 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹33,657.4 Cr | -0.8% | 0.3% | -5.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -0.8% |
0.3% |
-5.9% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses